- Title: Subtitle
- DNA methylation analysis of glioblastomas harboring FGFR3-TACC3 fusions identifies a methylation subclass with better patient survival
- Creators
- Zhichao Wu - National Cancer InstituteOsorio Lopes Abath Neto - University of Pittsburgh Medical CenterTejus A Bale - Memorial Sloan Kettering Cancer CenterJamal Benhamida - Memorial Sloan Kettering Cancer CenterDouglas Mata - Memorial Sloan Kettering Cancer CenterRust Turakulov - National Cancer InstituteZied Abdullaev - National Cancer InstituteDaniel Marker - University of Pittsburgh Medical CenterCourtney Ketchum - National Cancer InstituteHye-Jung Chung - National Cancer InstituteCaterina Giannini - Mayo Clinic in FloridaMartha Quezado - National Cancer InstituteDrew Pratt - National Institutes of HealthKenneth Aldape - National Cancer Institute
- Resource Type
- Letter/Communication
- Publication Details
- Acta neuropathologica, Vol.144(1), pp.155-157
- DOI
- 10.1007/s00401-022-02430-7
- PMID
- 35567606
- PMCID
- PMC10572100
- NLM abbreviation
- Acta Neuropathol
- ISSN
- 0001-6322
- eISSN
- 1432-0533
- Grant note
- DOI: 10.13039/100000054, name: National Cancer Institute
- Language
- English
- Date published
- 05/14/2022
- Academic Unit
- Pathology
- Record Identifier
- 9984277459202771
Letter/Communication
DNA methylation analysis of glioblastomas harboring FGFR3-TACC3 fusions identifies a methylation subclass with better patient survival
Acta neuropathologica, Vol.144(1), pp.155-157
05/14/2022
DOI: 10.1007/s00401-022-02430-7
PMCID: PMC10572100
PMID: 35567606
Details
Metrics
24 Record Views